Fact: You can’t tell how well a cancer treatment is working if you aren’t measuring how many new cancer cells the body is producing. In order to accurately monitor cancer progression, you must be able to assess the amount of tumor-mutation exosomal DNA present in the patient’s blood. Standard liquid biopsy testing does not differentiate live tumor cell DNA from dead tumor cell DNA and from exosomal DNA. This means that, while standard ctDNA tests (aka standard Liquid Biopsy tests) will show that a mutation is present, they won’t be able to tell you:
And this is the most important piece of information you need in order to assess how well a treatment is actually working! You can’t do that with standard liquid biopsy (ctDNA) – and that’s a problem we have solved.
Standard liquid biopsies ignore these important facts. Instead, they measure the amount of DNA from opposing processes and sources (i.e. dead tumor cells, live tumor cells, exosomes, and normal healthy cells) and combine everything together...and then use a bulk measurement of ctDNA to assess treatment efficacy! This is NOT precision oncology. And this is not the best that medical science has to offer physicians and their patients. You can do better.
Standard liquid biopsy tests only test for dead tumour cells in your blood. Liquid Biopsy Labs has designed a way to test for dead and LIVE tumour cells in your blood – the FIRST test of its kind. Make sure you are getting the WHOLE picture!
Liquid Biopsy Labs’ unique process provides doctors and their patients with a truly personalized, precise, and non-invasive tool to measure cancer growth and to show, quickly and accurately, how well your treatment plan is working.
"The capacity to detect new cancers, treatment-resistant variants, and tumor heterogeneity by noninvasive technology on the basis of tumor DNA in the blood promises to revolutionize cancer detection, prevention, and treatment." 1
For individuals with cancer, please visit our sister site, Cancer Treatment Options and Management, for Precision Oncology services designed just for you and your care team. CTOAM will coordinate your precision diagnosis – including your personalized liquid biopsy tests – and develop a targeted therapy plan based on what is truly causing your cancer to grow. Cancer Treatment Options and Management will partner with your oncologist to administer and monitor the very best treatment for your cancer.